TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF THE GLOBAL DIALYZER REPROCESSING MACHINES MARKET 26
1.4 LIMITATIONS 27
1.5 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 CURRENCY AND PRICING 32
2.5 DBMR TRIPOD DATA VALIDATION MODEL 33
2.6 MULTIVARIATE MODELLING 36
2.7 TYPE LIFELINE CURVE 36
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
2.9 DBMR MARKET POSITION GRID 38
2.10 MARKET END USER COVERAGE GRID 39
2.11 VENDOR SHARE ANALYSIS 40
2.12 SECONDARY SOURCES 41
2.13 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 PESTEL ANALYSIS 48
4.2 PORTER’S FIVE FORCES MODEL 49
4.3 STRATEGIC INITIATIVES 50
5 GLOBAL DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 51
5.1 REGULATORY SCENARIO IN THE U.S 51
5.2 REGULATORY SCENARIO IN CHINA 52
5.3 REGULATORY SCENARIO IN AUSTRALIA 52
6 MARKET OVERVIEW 54
6.1 DRIVERS 56
6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 56
6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 56
6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 57
6.2 RESTRAINTS 58
6.2.1 STRINGENT REGULATIONS FOR APPROVAL 58
6.2.2 POSSIBLE RISK OF INFECTIONS 58
6.3 OPPORTUNITIES 59
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 59
6.3.2 INCREASING FOCUS ON INFECTION CONTROL 60
6.4 CHALLENGES 60
6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 60
6.4.2 LACK OF STANDARDIZATION 61
7 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 62
7.1 OVERVIEW 63
7.2 SEMI-AUTOMATIC 66
7.3 AUTOMATIC 67
8 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 68
8.1 OVERVIEW 69
8.2 BENCHTOP 72
8.2.1 SEMI-AUTOMATIC 73
8.2.2 AUTOMATIC 73
8.3 STANDALONE 73
8.3.1 SEMI-AUTOMATIC 74
8.3.2 AUTOMATIC 74
9 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 75
9.1 OVERVIEW 76
9.2 DUAL STATION 79
9.3 SINGLE STATION 80
10 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY END USER 81
10.1 OVERVIEW 82
10.2 DIALYSIS CENTERS 85
10.3 HOSPITAL 86
10.4 HOME USE 87
11 GLOBAL DIALYZER REPROCESSING MACHINES MARKET, BY REGION 88
11.1 OVERVIEW 89
11.2 NORTH AMERICA 94
11.2.1 U.S. 101
11.2.2 CANADA 103
11.2.3 MEXICO 105
11.3 EUROPE 107
11.3.1 GERMANY 114
11.3.2 ITALY 116
11.3.3 SPAIN 118
11.3.4 RUSSIA 120
11.3.5 TURKEY 122
11.3.6 BELGIUM 124
11.3.7 REST OF EUROPE 126
11.4 ASIA-PACIFIC 127
11.4.1 CHINA 134
11.4.2 INDIA 136
11.4.3 AUSTRALIA 138
11.4.4 SINGAPORE 140
11.4.5 THAILAND 142
11.4.6 MALAYSIA 144
11.4.7 INDONESIA 146
11.4.8 PHILIPPINES 148
11.4.9 VIETNAM 150
11.4.10 REST OF ASIA-PACIFIC 152
11.5 SOUTH AMERICA 153
11.5.1 BRAZIL 160
11.5.2 ARGENTINA 162
11.5.3 REST OF SOUTH AMERICA 164
11.6 MIDDLE EAST AND AFRICA 165
11.6.1 SAUDI ARABIA 172
11.6.2 EGYPT 174
11.6.3 ISRAEL 176
11.6.4 REST OF MIDDLE EAST AND AFRICA 178
12 GLOBAL DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 179
12.1 COMPANY SHARE ANALYSIS: GLOBAL 179
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 180
12.3 COMPANY SHARE ANALYSIS: EUROPE 181
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 182
13 SWOT ANALYSIS 183
14 GLOBAL DIALYZER REPROCESSING MACHINES MARKET 184
14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 184
14.1.1 COMPANY SNAPSHOT 184
14.1.2 REVENUE ANALYSIS 184
14.1.3 COMPANY SHARE ANALYSIS 185
14.1.4 PRODUCT PORTFOLIO 185
14.1.5 RECENT DEVELOPMENTS 185
14.2 HEMANT SURGICAL INDUSTRIES LTD. 186
14.2.1 COMPANY SNAPSHOT 186
14.2.2 REVENUE ANALYSIS 186
14.2.3 COMPANY SHARE ANALYSIS 187
14.2.4 PRODUCT PORTFOLIO 187
14.2.5 RECENT DEVELOPMENTS 187
14.3 SAUBERN 188
14.3.1 COMPANY SNAPSHOT 188
14.3.2 COMPANY SHARE ANALYSIS 188
14.3.3 PRODUCT PORTFOLIO 189
14.3.4 RECENT DEVELOPMENTS 189
14.4 P.K. SCIENTIFIC & CHEMICALS 190
14.4.1 COMPANY SNAPSHOT 190
14.4.2 PRODUCT PORTFOLIO 190
14.4.3 RECENT DEVELOPMENT 190
14.5 LABSMED. 191
14.5.1 COMPANY SNAPSHOT 191
14.5.2 COMPANY SHARE ANALYSIS 191
14.5.3 PRODUCT PORTFOLIO 192
14.5.4 RECENT DEVELOPMENTS 192
14.6 ATLANTIC BIOMEDICAL 193
14.6.1 COMPANY SNAPSHOT 193
14.6.2 COMAPYN SHARE ANALYSIS 193
14.6.3 PRODUCT PORTFOLIO 194
14.6.4 RECENT DEVELOPMENT 194
14.7 ADVIN HEALTH CARE 195
14.7.1 COMPANY SNAPSHOT 195
14.7.2 PRODUCT PORTFOLIO 195
14.7.3 RECENT DEVELOPMENTS 195
14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 196
14.8.1 COMPANY SNAPSHOT 196
14.8.2 PRODUCT PORTFOLIO 196
14.8.3 RECENT DEVELOPMENT 196
14.9 CLINIVA HEALTHCARE 197
14.9.1 COMPANY SNAPSHOT 197
14.9.2 PRODUCT PORTFOLIO 197
14.9.3 RECENT DEVELOPMENT 197
14.10 GERYFALCON HEALTHCARE PVT. LTD. 198
14.10.1 COMPANY SNAPSHOT 198
14.10.2 PRODUCT PORTFOLIO 198
14.10.3 RECENT DEVELOPMENT 198
14.11 NANOTECH 199
14.11.1 COMPANY SNAPSHOT 199
14.11.2 PRODUCT PORTFOLIO 199
14.11.3 RECENT DEVELOPMENTS 199
14.12 WESLEY BIOTECH 200
14.12.1 COMPANY SNAPSHOT 200
14.12.2 PRODUCT PORTFOLIO 200
14.12.3 RECENT DEVELOPMENT 200
15 QUESTIONNAIRE 201
16 RELATED REPORTS 204
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
